Searched for
ESOPS AND SHAREHOLDING DILUTION
Zepto's market position; TCS' AI verdict at AGMZepto pulls ahead of Swiggy Instamart on orders, but heavy burn continues. This and more in today's ETtech Top 5.
Inside Zepto’s IPO filing — the key takeawaysQuick commerce platform Zepto has filed its updated draft papers for public listing, revealing detailed financials and operational metrics....
Apollo Hospitals Q4 Results: Cons PAT jumps 36% YoY to Rs 529 crore, revenue rises 18%; Rs 10 per share dividend declaredApollo Hospitals reported strong Q4 FY26 results: consolidated PAT surged 36% YoY to Rs 529 crore, and revenue increased 18% to Rs 6,605 cr...
Take Companies Act beyond ESOPs fablesNew rules for company executive pay are here. Finance Minister Nirmala Sitharaman has updated the Companies Act. These changes introduce ne...
Deepinder Goyal to surrender Esops worth Rs 900-1,000 crore upon resigning as Eternal CEOLater during the company's quarterly analysts call, Eternal CFO Akshant Goyal said that the exercise will result in around 3.3 crore shares...
Billionaire Deepinder Goyal to sacrifice Rs 1,000 crore Eternal ESOPs on giving up CEO roleDeepinder Goyal is giving up more than ₹1,000 crore worth of unvested ESOPs as he steps down as Group CEO of Eternal, returning 3.3 crore s...
Explained: 8 reasons why companies do share buybacks and what it means to investorsInfosys’ upcoming buyback proposal highlights why companies repurchase shares. Buybacks boost EPS, signal undervaluation, and stabilise sto...
ETtech Explainer: Sebi’s new Esop rules and reverse-flipping impact on IPO-bound startupsPreviously, it was mandated that founders be classified as "promoters" when filing their initial public offering (IPO) documents. After tha...
Sebi board to discuss changes in ESOP rules for startup founders and PSU delistingSebi is considering allowing startup founders to retain ESOPs post-IPO, addressing concerns about dilution and aligning founder incentives ...
PB Fintech invests Rs 539 crore in healthcare armPB Fintech has invested ₹539.4 crore in its health subsidiary, PB Healthcare Services, as part of a larger Rs 1,461.6 crore seed funding ro...
Sebi may allow startup founders to retain EsopsFounders of new-age technology companies often receive Esops, or equity-linked instruments over cash-based remunerations, in formative year...
Sebi tweaks disclosure requirements for shareholding patterns to improve clarityMarkets regulator Sebi on Thursday introduced modifications to the disclosure requirements for shareholding patterns in a bid to improve th...
JM Financial cuts Zomato's target price by 8% on ESOP costsJM Financial has lowered Zomato's target price to Rs 230 from Rs 250, noting that ESOP costs are no longer considered one-off expenses foll...
Zomato gets shareholder approval for Esop plan, gives up pursuit of NBFC licenceFood delivery company Zomato had proposed an Esop pool of 183 million shares. The new plan would mean a 2% stake dilution for existing shar...
Promoters can use ETF route to meet minimum public shareholding normIf they opt for increasing public holding pursuant to exercise of options and allotment of shares under an ESOP scheme, it would be subject...
FIs oppose liberal stock options, pay deals for top execs of new-age cosCorporate governance experts had recommended investors to vote against the company's remuneration proposals for reappointment of two direct...
Institutional investors oppose liberal stock options, payouts to startup executivesLate last month, 82% of investors voted against an Employee Stock Options (ESOP) scheme proposed by Zomato. Similarly, 72% of institutions ...
India Inc's move to offer ESOPs to employees leave investors unimpressedCompanies look at Esops as a way to compensate senior managers who have taken steep pay cuts after the pandemic and reduce monthly cash out...
Your ESOPs can be HNIs’ investment opportunityEmployee stock options, including those in unlisted companies, is a new bet many institutions and rich investors are taking.
BAT turns down ITC proposal to hand out ESOPsBAT didn’t support the move as the London firm didn’t want its 29% stake getting reduced.